All news items
The Pediatric Praziquantel Consortium Announces Positive Phase III Results for Arpraziquantel To Treat Schistosomiasis
The Pediatric Praziquantel Consortium completes its pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million preschool-aged children with schistosomiasis.
Schistosomiasis Talks at the ASTMH 2021 Annual Meeting
Wondering which session to go to at the American Society of Tropical Medicine and Hygiene Annual Meeting? Have no fear, we have all the schistosomiasis related talks here.
All sessions are in U.S. Eastern Time (EST).
COR-NTD Grants | Request for Proposals by NTD Support Center with support from USAID
Two requests for proposals have been announced by the Neglected Tropical Diseases (NTD) Support Center, a program of The Task Force for Global Health. Projects will be funded with support from USAID through the NTD-SC.
Deadline 31 Jan 2022
Merck Schistosomiasis Research Grant winners announced
Merck is dedicated to accelerating innovation and advancing science for most neglected populations. That’s why they want to catalyze research in an open innovation spirit as well as reduce the financial hurdles.
Global Grand Challenges | Innovations in Eliminating Neglected Tropical Diseases
Global Grand Challenges has partnered with Kikundi, a community of practice for NTD program managers in Africa, to identify areas for transformational innovation in service of national NTD programs.
Deadline: 13 Jan 2022
FIND DxConnect virtual biobank directory
FIND has established a virtual platform for researchers and institutions to make their NTD research interests and sample collections visible to the international community, to enable sharing of biological materials, and to attract collaborative projects.
Article | KEMRI testing bilharzia rapid test kit
Scientists at the Kenya Medical Research Institute (KEMRI) are testing the CAA bilharzia rapid testing kit that will give results in 20 minutes - via Nation
Interview | Could COVID-19 pandemic have led to less focus on other diseases?
Interview with Dr. Eugene Ruberanziza, Senior Technical Adviser at the END Fund about the pandemic and its linkage to other infectious diseases, like NTDs.
Financial Times | Budget cuts hinder efforts to eliminate neglected tropical diseases
As donated drugs near expiry, time is running out to distribute them, just as the peak season for infection approaches
Schistosomiasis Research Grant
Merck is a leading company in the fight against Schistosomiasis. This initiative is all about catalyzing research. They want to give promising researchers what they need – and when they need it most.
The Children’s Investment Fund Foundation and Crown Agents join forces to accelerate the elimination of Neglected Tropical Diseases across five African countries
Work is commencing on the new Accelerate Resilient, Innovative, and Sustainable Elimination of NTDs (ARISE-NTDs) programme this September to support governments to control and eliminate three endemic Neglected Tropical Diseases from Kenya, Mozambique, Uganda, Tanzania and Zanzibar, and Zambia.
Call for Entries | Virtual Innovation Lab at COR-NTD
Have you been involved with the development of a technology or advance with the potential to help NTD programs? If so, COR-NTD invites you to apply to showcase your innovation for the hundreds of researchers, donors and program implementers
Deadline 15 September